v3.26.1
Note 9 - Stock Based Compensation
6 Months Ended
Jun. 30, 2026
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

9. Stock Based Compensation

 

2019 Stock Plan

 

The Aemetis, Inc. Amended and Restated 2019 Stock Plan (the “2019 Stock Plan”) allows our Board of Directors or delegated Board committee to grant Incentive Stock Options, Non-Statutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares, and other stock or cash awards to employees, directors, and consultants. During the six months ended June 30, 2026, we issued stock options to employees exercisable for 1.9 million shares and we issued 379 thousand shares of stock to members of our Board of Directors as compensation. The following table summarizes activity under the 2019 Stock Plan during the six months ending  June 30, 2026:

 

 

 

Shares Available for Grant

 

 

Number of Shares Outstanding

 

 

Weighted-Average Exercise Price

 

Balance as of December 31, 2025

 

 

81

 

 

 

8,610

 

 

$

3.91

 

Authorized

 

 

2,749

 

 

 

-

 

 

 

-

 

Options Granted

 

 

(1,928

)

 

 

1,928

 

 

 

2.60

 

Common stock granted

 

 

(379

)

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

(181

)

 

 

0.78

 

Forfeited/expired

 

 

294

 

 

 

(294

)

 

 

2.73

 

Balance as of June 30, 2026

 

 

817

 

 

 

10,063

 

 

$

3.75

 

 

The options outstanding as of  June 30, 2026 include vested rights to purchase 6.9 million shares and the remaining purchase rights are not yet vested.

 

Stock-based Compensation Expense

 

Stock-based compensation is accounted for in accordance with ASC 718, Compensation - Stock Compensation, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and consultants based on estimated fair value on the grant date. We estimate the fair value using the Black-Scholes option pricing model and recognize that fair value as an expense over the vesting period of each grant using the straight-line method. The Black-Scholes valuation model for stock-based compensation expense requires us to make assumptions and judgments about the variables used in the calculation, including the expected term (the period of time that the options granted are expected to be outstanding), the volatility of our common stock, a risk-free interest rate, expected dividends, and expected forfeitures. We use the simplified calculation of expected term described in SEC Staff Accounting Bulletin Topic 14, Share-Based Payment. Volatility is based on an average of the historical volatility of Aemetis, Inc. common stock during the period of time preceding the date of option issuance that matches the term of the option grant. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the treasury maturity term corresponding with the expected life of the option. We use an expected dividend yield of zero, as we do not anticipate paying any dividends in the foreseeable future. Expected forfeitures are assumed to be zero due to the small number of plan participants. To the extent actual forfeitures occur, the difference is recorded as an adjustment in the scheduled expense during the period of the forfeiture.

 

The weighted average fair value calculations for the options granted during the six months ended June 30, 2026 and 2025, are based on the following assumptions:

 

 

 

For the six months ended June 30,

 

Description

 

2026

 

 

2025

 

Dividend-yield

 

 

- %

 

 

- %

Risk-free interest rate

 

 

3.9 %

 

 

4.3 %

Expected volatility

 

 

111.0 %

 

 

113.5 %

Expected life (years)

 

 

5.81

 

 

 

5.81

 

Market value per share on grant date

 

$ 2.60

 

 

$ 2.73

 

Fair value per option on grant date

 

$ 2.18

 

 

$ 2.32

 

 

During the six months ended June 30, 2026 and 2025, we recognized $2.8 million and $3.7 million of stock-based compensation expense. During these periods, we granted 379 thousand and 396 thousand shares of common stock under the 2019 Stock Plan, respectively, with an average market value on date of grant of $2.44 and $2.73, respectively, per share. 

 

As of  June 30, 2026, we had $6.1 million of total unrecognized compensation expense for option issuances, which we will amortize over the remaining vesting period for each applicable grant, which has a weighted average of 2.17 years as of  June 30, 2026.